|
Chugai Pharmaceutical Co Ltd - Comparative Business Analysis Snapshot
Business Description
Chugai Pharmaceutical Co Ltd. The Group's principal activity is to manufacture pharmaceutical products. The products include prescription medicines for central nervous, cardiovascular, respiratory, gastrointestinal and metabolic systems, hormones and diagnostic products and OTC drugs. The operations are carried out through the following divisions: Pharmaceuticals and Other operations. The major products are epogin, alfarol, neutrogin, sigmart , suvenyl, oxarol, rocephin, renagel and rythmodan.
Competitor Analysis
This analysis compares Chugai Pharmaceutical Co Ltd with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
